Geneious

Geneious, founded in 2003, is a technology leader providing intuitive bioinformatics software for DNA data analysis. Their mission is to empower scientists in biology and medicine by enabling direct analysis, interpretation, and application of molecular sequence data. Biomatters develops flagship applications like Geneious Prime and Geneious Biologics, designed to streamline complex computational tasks and data management, allowing researchers to concentrate on scientific discovery rather than software intricacies. This focus on easing the transition from laboratory work to computational biology is central to their strategy, making advanced bioinformatics accessible.

Operating with a team of 500 - 1,000 employees across 2 locations, Geneious has established a significant global presence, with users in 125 countries worldwide. Their solutions are utilized by over 4,000 universities, research institutes, and businesses, underscoring their market leadership in bioinformatics. The company emphasizes creating integrated, visually appealing, and user-friendly bioinformatics tools, constantly innovating to meet customer needs. Meet Geneious's team to understand the expertise driving these advanced solutions. Their commitment to user experience ensures rapid adoption and productivity gains for scientists globally.

Geneious Prime, a core offering, is equipped with fundamental molecular biology and sequence analysis tools, including alignment, tree building, cloning, and primer design. The software features a user-friendly interface, simple drag-and-drop data import, and comprehensive support, facilitating quick implementation. Biomatters' bioinformatics solutions are market leaders, continuously iterated and innovated to provide comprehensive functionality. The company's B2B focus and technological advancements in engineering software and software development ensure they remain at the forefront of biological data analysis.